• Singapore’s Largest Respiratory Medicine Research Collaboration, New Brain Health Intervention Research Initiative, More

    Clinical Research News | A first-of-its-kind benchtop platform that enables researchers to assess multiple critical quality attributes of cell samples in a single automated workflow; a prospective pan-tumor therapeutic trial designed to evaluate the efficacy and safety of numerous FDA-approved cancer therapies in new, biomarker-guided patient populations; and more.

    Sep 29, 2022

  • Follow the Money: New Radiation and Immunotherapy Research Initiative, NIH Funds Alzheimer’s and Dementia Research, More

    Clinical Research News | Funding for comparative clinical effectiveness research for patients and caregivers, AI-based biomedical research, diversity in genomic research, and more.

    Sep 28, 2022

  • Balancing People and Technology in Clinical Adjudication

    Clinical Research News | Event adjudication is critical to clinical research for developing life-improving therapies. Implementing a well-managed adjudication program provides sponsors with peace of mind and an unbiased evaluation they may ultimately need to earn regulatory approval.

    Sep 23, 2022

  • Community Registry Grows Research Abilities Of Pulmonary Fibrosis Foundation

    Clinical Research News | In July, the Pulmonary Fibrosis Foundation (PFF) launched the PFF Community Registry to begin collecting data directly from patients in the U.S. with pulmonary fibrosis (PF) and interstitial lung disease (ILD)—together with their nonprofessional caregivers and biological family members—as well as lung transplant recipients previously diagnosed with PF or ILD.

    Sep 21, 2022

  • 3 Ways to Communicate Your Value to Trial Participants

    Clinical Research News | Although we’re seeing an increasing trend of site networks and academic research centers insourcing technology solutions themselves, unless they’re offered an Adaptive Experience that lets them choose how they want to participate at every step of the trial, they aren’t given a choice about using the technology. Keeping technology top of mind is critically important for research solutions to succeed.

    Sep 16, 2022

  • Mount Sinai Aims To Enroll One Million People In Genetic Sequencing Project

    Clinical Research News | The greater New York metropolitan area is the epicenter of an ambitious human genome sequencing research project newly launched by Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai. If the vision is realized, Mount Sinai will enroll a million patients into a study over the next five years that will sequence and analyze the DNA in their blood to tease out the role of genetics and environment on health.

    Sep 15, 2022

  • Public More Protective Of Their Health Information Than Their Biospecimens

    Clinical Research News | In the ongoing debate about whether biospecimens should be covered by human subjects research regulations, bioethicists at the University of Michigan recently added a critical datapoint in disproving one of the arguments—namely, that the public feels more protective of their biospecimens than their health information.

    Sep 14, 2022

  • IVDR Creating ‘Significant Challenges’ For Global Precision Medicine Trials

    Clinical Research News | The impact of Europe’s In Vitro Diagnostic Medical Devices Regulation on global trials for precision medicine was shared at the recent Next Generation Dx Summit held in Washington, DC. IVDR is finally coming into force and creating “significant challenges” for pharmaceutical companies sponsoring studies involving biomarker testing on EU patient samples.

    Sep 13, 2022

  • The Hospital’s Evolving Role in Complementing Clinical Trials

    Clinical Research News | People of color comprise approximately 39 percent of the U.S. population but typically only represent 2 to 16 percent of trial patients. Unlocking the clinical data captured by hospitals and health systems may be the key to closing gaps in care.

    Sep 9, 2022

  • DTRA Releases Lexicon for Decentralized Clinical Research

    Clinical Research News | The Decentralized Trials & Research Alliance announced the release of the DTRA Glossary, an interactive lexicon to provide a consistent vocabulary for and improve the global adoption of decentralized research.

    Sep 8, 2022

  • Moving the Needle: How the Practice of Pharmacy Addresses Key Issues in Clinical Research

    Clinical Research News | In the latest episode of the Scope of Things podcast, Founder and CEO Gerald Finken speaks with host Deborah Borfitz about RxE2, a community-based decentralized trial technology company spearheaded by pharmacists, designed to integrate the practice of pharmacy into every aspect of clinical trials.

    Sep 6, 2022

  • How Patient-Centered Strategies Are Transforming Clinical Trials

    Clinical Research News | Patient centricity is a term on everyone’s lips right now. The life science sector is coming round to the idea that, by putting the needs of the patient at the heart of drug development, we can improve the patient experience and reduce development timelines while creating significant business value.

    Sep 2, 2022

  • The NIH’s Strategic Plan to Cure Hepatitis B, Merck’s New Clinical Research Data Platform, More

    Clinical Research News | An ultra-sensitive assay accurately measures antibodies against SARS-CoV-2; a single-vendor gene-to-mRNA service delivers custom mRNA within six to eight weeks; Mayo Clinic manufactures biotherapeutics for rare and complex conditions; and more.

    Aug 31, 2022

  • Follow the Money: Cross-Disciplinary Viral Emergence Research Institute, New Anti-Aging Research Initiative, More

    Clinical Research News | Funding for Johns Hopkins international tuberculosis research project, new yellow fever, rabies, and chronic hepatitis B vaccines, multiple sclerosis research grants, and more.

    Aug 30, 2022

  • When Will We Solve the Patient Engagement Dilemma?

    Clinical Research News | Adopting countless tools to engage patients and capture information in trials limits the opportunity to share common learnings, establish standard procedures, or gain economies of scale through replication across studies. With standardized processes and workflows, sponsors can reduce implementation complexity and create a repeatable model across most studies with minor changes.

    Aug 26, 2022

  • ‘Laboratory For Motion’ Uses AI To Turn Movements Into Clinical Endpoints

    Clinical Research News | Movement can now be used as a functional biomarker and endpoint for all sorts of treatments—including orthopedic surgery for bad knees and hips, spinal cord stimulation for debilitating back pain, weight-loss programs for obesity, and even laser surgery for glaucoma.

    Aug 25, 2022

  • AI Could Help Spot Difficult-To-Detect Pancreatic Cancer Sooner

    Clinical Research News | Radiomics-based machine learning models have been shown to do an impressive job of detecting pancreatic cancer on pre-diagnostic CT scans several months before symptoms appear, suggesting that one day the disease will more often be diagnosed at a stage where a surgical cure may be possible.

    Aug 23, 2022

  • Survey Suggests Alzheimer’s Research Is Missing the Boat

    Clinical Research News | A research team is advocating for a more data-driven approach to Alzheimer’s research where sets of biological pathways get grouped with mechanisms the body itself uses to ward off the disease.

    Aug 18, 2022

  • Long COVID and Chronic Fatigue Syndrome Have A Lot In Common

    Clinical Research News | Evidence is emerging that long COVID (formally “post-acute sequelae SARS-CoV-2 infection,” or PASC) bears a striking, molecular-level resemblance to the disabling and complex illness now known as myalgic encephalomyelitis/chronic fatigue syndrome.

    Aug 16, 2022

  • A Blended Solution–How Midsize Pharmaceutical and Biotech Companies Can Optimize the Delivery of Their Clinical Trials

    Clinical Research News | Large biopharma companies use two outsourcing models to deliver their clinical trial portfolios: CRO and FSP. But what about mid-sized companies? As they experience significant growth in development, have their operating models grown with them?

    Aug 12, 2022